Oramed Pharmaceuticals (ORMP) Operating Expenses (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Operating Expenses came in at $3.7 million in Q1 2026, down 18.92% YoY from $4.5 million in Q1 2025, and down 35.49% on a QoQ basis from $5.7 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Operating Expenses (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 15 years of Operating Expenses data on file, last reported at $3.7 million in Q1 2026.
- Quarterly Operating Expenses fell 18.92% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.2 million (down 0.59% YoY) and the FY2025 annual result came in at $15.1 million, up 18.15% from the prior year.
- Operating Expenses declined to $3.7 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $11.8 million in Q4 2022 to a low of $2.4 million in Q3 2025.
- A 5-year average of $4.6 million and a median of $3.6 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses sank 67.04% — and 2025, when it jumped 57.77%.
- Tracing ORMP's Operating Expenses over 5 years: stood at $11.8 million in 2022, then slumped by 67.04% to $3.9 million in 2023, then retreated by 7.27% to $3.6 million in 2024, then jumped by 57.77% to $5.7 million in 2025, then sank by 35.49% to $3.7 million in 2026.
- The last three Operating Expenses figures came in at $3.7 million (Q1 2026), $5.7 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 541.02 Mn |
| 10 | Oramed Pharmaceuticals | 199.87 Mn | 199.87 Mn | - | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.77 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 5.67 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 3.56 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | 5.69 Mn |
| Dec 31, 2022 | 11.76 Mn |
| Sep 30, 2022 | 3.52 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 11.33 Mn |
| Aug 31, 2021 | 20.99 Mn |
| Nov 30, 2019 | 3.10 Mn |